Compugen Second Quarter 2015 Conference Call Scheduled for Tuesday, August 4, 2015 at 10:00 AM ET
July 27 2015 - 7:00AM
Business Wire
Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug
discovery company, today announced that the Company will host a
conference call at 10:00 AM ET on Tuesday, August 4, 2015 to review
the second quarter 2015 results. The quarterly results will be
released on the Company’s website (www.cgen.com) prior to the
conference call.
To access the conference call, please dial 1-888-668-9141 from
the US, or + 972-3-918-0609 internationally. The call will also be
available via live webcast through Compugen’s website, located at
the following link.
A replay of the conference call will be available beginning
approximately two hours after the completion of the live conference
call. To access the replay, please dial 1-888-326-9310 from the US
or +972-3-925-5925 internationally. The replay will be available
through August 6, 2015.
About Compugen
Compugen is a leading predictive drug discovery company focused
on monoclonal antibodies and therapeutic proteins to address
important unmet needs in the fields of oncology and immunology. The
Company utilizes a broad and continuously growing integrated
infrastructure of proprietary scientific understandings and
predictive platforms, algorithms, machine learning systems and
other computational biology capabilities for the in silico (by
computer) prediction and selection of novel drug target candidates,
which are then advanced in its Pipeline Program. The discovery and
development of monoclonal antibody therapeutic candidates against
selected Compugen-discovered novel target candidates is performed
by Compugen’s wholly-owned US subsidiary located in South San
Francisco. The Company's business model includes collaborations
covering the further development and commercialization of product
candidates at various stages from its Pipeline Program and various
forms of research and discovery agreements, in both cases providing
Compugen with potential milestone payments and royalties on product
sales or other forms of revenue sharing. For additional
information, please visit Compugen's corporate website at
www.cgen.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150727005487/en/
Compugen Ltd.Tsipi Haitovsky, +972-52-598-9892Global Media
Liaisontsipih@cgen.com
Compugen (NASDAQ:CGEN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Compugen (NASDAQ:CGEN)
Historical Stock Chart
From Jul 2023 to Jul 2024